🔎 Trials Near Me

መነሻ › ከባድ ሰውነት › ከንታኪ

በከንታኪ ለከባድ ሰውነት የሚደረጉ ክሊኒካዊ ጥናቶች

ለከባድ ሰውነት የሚደረጉ 27 ጥናቶች በከንታኪ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በከንታኪ ውስጥ ያሉ ከተሞች

Official study text (English)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • L-MARC Research Center /ID# 282008, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • AMR Clinical - Lexington, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07685808

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Monroe Biomedical Research, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Gastroenterology Health Partners, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Norton Children's Endocrinology, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Health Partners, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • AMR Clinical, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Monroe Biomedical Research - Louisville, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Monroe Biomedical Research - Louisville, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • The Research Group of Lexington LLC, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Monroe Biomedical Research, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • L-MARC Research Center, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Monroe Biomedical Research - Louisville, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  • Equity Medical - Bowling Green, Bowling Green
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

  • The Alliance for Multispecialty Research LLC AMR, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07745504

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Monroe Biomedical Research, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07684235

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

  • University of Kentucky, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 4ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ35 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT05051436

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • The Research Group of Lexington LLC, Lexington
  • UofL Health Care Outpatient, Louisville
  • Research Integrity Global, LLC, Owensboro
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Monroe Biomedical Research, LLC, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07654361

Cannabis for Obesity Trial

  • University of Kentucky, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06137365

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • L-MARC Research Center, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT07477704

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

  • University of Kentucky, Lexington
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ12 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ21 ጁላይ 2026 · NCT06967389

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

  • Monroe Biomedical Research, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT07570758

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

  • MBX Biosciences Investigational Site, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁን 2026 · NCT07142707

2024 Tirzepatide-Bariatric Surgery

  • University of Kentucky, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT06721507

Adrenergic Cholinergic Enteric Measures/Mapping

  • University of Louisville, Louisville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ10 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጃንዩ 2025 · NCT04013282

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።